Back to ZNTL
GOLDMAN SACHS GROUP INC → ZNTL
GOLDMAN SACHS GROUP INC ZNTL Position History
Zentalis Pharmaceuticals, Inc. • Healthcare
Quarters held
14
Latest value
$172K
Q3 2026
Peak value
$1.5M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $933K |
| Q2 2025 | $67K |
| Q3 2025 | $462K |
| Q3 2025 | $59K |
| Q4 2025 | $52K |
| Q4 2025 | $108K |
| Q4 2025 | $108K |
| Q4 2025 | $52K |
| Q1 2026 | $963K |
| Q1 2026 | $120K |
| Q2 2026 | $1.5M |
| Q2 2026 | $337K |
| Q3 2026 | $335K |
| Q3 2026 | $172K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $172K | 62.0K | — | — |
| Q3 2026 | $335K | 120.9K | — | — |
| Q2 2026 | $337K | 69.6K | — | — |
| Q2 2026 | $1.5M | 303.0K | — | — |
| Q1 2026 | $120K | 51.2K | — | — |
| Q1 2026 | $963K | 411.5K | — | — |
| Q4 2025 | $52K | 38.5K | — | — |
| Q4 2025 | $108K | 79.7K | — | — |
| Q4 2025 | $108K | 79.7K | — | — |
| Q4 2025 | $52K | 38.5K | — | — |
| Q3 2025 | $59K | 39.4K | — | — |
| Q3 2025 | $462K | 305.8K | — | — |
| Q2 2025 | $67K | 57.3K | — | — |
| Q2 2025 | $933K | 804.4K | — | — |